Document:

Exhibit 4.3

 

certificate
of DESIGNATION OF

SERIES A
REDEEMABLE PARTICIPATING CONVERTIBLE PREFERRED STOCK

of

Nanoflex
power corporation

 

 

 

Pursuant to the provisions of Section 607.0601

 

of the Florida Business Corporation Act

 

 

 

NanoFlex Power Corporation
(the “Corporation”), a corporation organized and validly existing under the Florida Business Corporation Act
(“FBCA”), hereby certifies that the following resolutions have been duly adopted by the Corporation’s
Board of Directors by means of a Unanimous Consent of the Board of Directors executed on February 15, 2019, pursuant to authority
conferred upon the Board of Directors by the Corporation’s Certificate of Incorporation and the FBCA:

 

WHEREAS,
the Certificate of Incorporation of the Corporation (the “Certificate”), authorizes a class of stock designated
as Preferred Stock (the “Preferred Stock”), comprising 100,000,000 shares, par value $0.0001 per share, provides
that such Preferred Stock may be issued from time to time in one or more series, and vests authority in the Board of Directors,
within the limitations and restrictions stated in the Certificate, to fix or alter the voting powers, designations, preferences
and relative participating, optional or other special rights, rights and terms of redemption, the redemption price or prices and
the liquidation preferences of any series of Preferred Stock within the limitations set forth in the Florida Business Corporation
Act;

 

WHEREAS,
it is the desire of the Board of Directors to designate one new series of Preferred Stock and to fix the voting powers, designations,
preferences and rights, and the qualifications, limitations or restrictions thereof, as provided herein.

 

NOW, THEREFORE,
BE IT RESOLVED, that the Corporation does hereby designate up to 10,000 shares of the authorized but unissued Preferred Stock
as Series A Redeemable Participating Convertible Preferred Stock (the “Series A Preferred”) and does hereby
fix the powers, preferences and relative participating, optional or other special rights and qualifications, limitations or restrictions
of the Series A Preferred to be as follows:

 

     

     

    

 

SERIES
A CONVERTIBLE PREFERRED STOCK

 

A. Designation.
10,000 shares of the authorized, but undesignated preferred stock, $0.0001 par value per share, of the Corporation are hereby constituted
as a series of the preferred stock designated as “Series A Redeemable Participating Convertible Preferred Stock” (“Series
A Preferred”). The date on which the Corporation initially issues any share of Series A Preferred shall be deemed to
be its “date of issuance” regardless of the number of times transfer of such share is made on the stock records
maintained by or for the Corporation and regardless of the number of certificates which may be issued to evidence such share. The
Series A Preferred shall have rights and preferences relative to all other classes and series of the capital stock of the Corporation
as set forth herein.

 

B. Dividends.
The holders of Series A Preferred shall be entitled to receive dividends when and as declared by the Board of Directors. No dividends
(other than those payable solely in Common Stock) shall be paid on the Common Stock or any class or series of capital stock ranking
junior, as to dividends, to the Series A Preferred during any fiscal year of the Corporation until there shall have been paid or
declared and set apart during that fiscal year for the holders of the Series A Preferred a dividend in an amount per share equal
to (i) the number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock times (ii) the amount per
share of the dividend to be paid on the Common Stock.

 

C.
Preference on Liquidation.

 

1. Upon the
occurrence of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary (a “Liquidating
Event”), each holder of Series A Preferred then outstanding shall be entitled to receive, out of the assets of the Corporation
available for distribution to its stockholders, before any payment shall be made in respect of the Common Stock, or other series
of preferred stock then in existence that is outstanding and junior to the Series A Preferred upon liquidation, an amount per share
of Series A Preferred equal to three (3) times the price such holder paid to purchase such Series A Preferred (the “Purchase
Price”) (as adjusted for any stock combination, stock dividend, stock split, recapitalization or other similar transaction
occurring after the first date of issuance of the Series A Preferred), plus, accrued and unpaid dividends (the “Preferred
Liquidation Preference”). Such Preferred Liquidation Preference shall be secured by a first priority security interest
on all of the Corporation’s assets. For purposes of this Subsection C.1, the following events shall be deemed a Liquidating
Event: (i) a sale, lease, exchange, exclusive license which has the same effect as a sale of all or substantially all of the Corporation’s
assets or other disposition of all or substantially all of the Corporation’s assets in one transaction or a series of related
transactions and (ii) a merger, tender offer, reorganization, business combination or other transaction as a result of which (a)
holders of the Corporation’s issued and outstanding voting securities immediately before such transaction own or control
less than a majority of the voting securities of the continuing or surviving entity immediately after such transaction or (b) any
of the Series A Preferred is converted into any other property or security (for the avoidance of doubt, other than (1) conversion
of the Series A Preferred into Common Stock as provided herein or (2) in connection with an internal restructuring, reorganization,
recapitalization or equity financing of the Corporation approved by holders of the Series A Preferred).

 

    2

     

    

 

2. Written notice
of any such Liquidating Event stating a payment date, the place where such payment shall be made and the amount of each payment
in liquidation shall be given by first class mail, postage prepaid, not less than ten (10) days prior to the payment date stated
therein, to each holder of record of the Series A Preferred at such holder’s address as shown in the records of the Corporation.
If upon the occurrence of a Liquidating Event, the assets of the Corporation available for distribution to its stockholders shall
be insufficient to pay the holders of the Series A Preferred and all other classes or series of stock ranking on a parity with
the Series A Preferred upon liquidation the full amount to which they shall be entitled, the holders of the Series A Preferred
shall share ratably with any other such class or series in any distribution of assets according to the amounts that would be payable
in respect of the shares held by each of them upon such distribution if all amounts payable on or with respect to said shares were
paid in full. Upon the occurrence of a Liquidating Event, in the event the Preferred Liquidation Preference is paid in full, the
holders of Series A Preferred shall share ratably with holders of Common Stock in any distribution of any remaining assets of the
Corporation.

 

D. Voting.
Except as otherwise expressly provided herein or as required by law, the holders of shares of Series A Preferred shall vote together
with the holders of Common Stock as a single class. The holder of each share of Series A Preferred (i) shall be entitled to the
number of votes with respect to such share equal to the number of shares of Common Stock into which such share of Series A Preferred
could be converted on the record date for the subject vote or written consent (or, if there is no such record date, then on the
date that such vote is taken or consent is effective) and (ii) shall be entitled to notice of any stockholders’ meeting in
accordance with the Bylaws of the Corporation. Fractional votes shall not be permitted, and any fractional voting rights resulting
from the above formula (after aggregating all shares of Common Stock into which shares of Series A Preferred held by each holder
could be converted) shall be reduced to the nearest whole number.

 

E. Conversion
Rights.

 

1. Conversion
Price. Each share of Series A Preferred Stock shall be convertible into shares of the Corporation’s common stock, par
value $0.0001 per share (the “Common Stock”), at a conversion price (the “Conversion Price”)
equal to $0.10, subject to adjustment as set forth herein. The Conversion Price may not be changed absent written agreement of
the Corporation.

 

2.
Right to Convert. Each share of Series A Preferred and all accrued and unpaid dividends thereon shall be convertible at
the option of the holder thereof, at any time after the issuance of such share, into fully paid and nonassessable shares of Common
Stock of the Corporation. The number of shares of Common Stock into which each share of the Series A Preferred may be converted
shall be determined by dividing the sum of the Purchase Price of the Series A being converted and any accrued and unpaid dividends
by the Conversion Price.

 

    3

     

    

 

3. Mechanics
of Conversion.

 

(i) The
holder of any shares of Series A Preferred may exercise the conversion rights as to such shares or any part thereof by delivering
to the Corporation during regular business hours, at the office of any transfer agent of the Corporation for the Series A Preferred,
or at the principal office of the Corporation or at such other place as may be designated by the Corporation, the certificate or
certificates for the shares to be converted, duly endorsed for transfer to the Corporation or accompanied by a written instrument
or instruments of transfer (if required by it), accompanied by written notice stating that the holder elects to convert all or
a number of such shares represented by the certificate or certificates. Such notice shall also state such holder’s name or
the names of the nominees in which such holder wishes the certificate or certificates for shares of Common Stock to be issued.
Conversion shall be deemed to have been effected on the date when such delivery is made, and such date is referred to herein as
the “Conversion Date.” As promptly as practicable thereafter (but in any event within three (3) business days
thereafter), the Corporation shall issue and deliver to such holder, at such office or other place designated by the Corporation,
a certificate or certificates for the number of full shares of Common Stock to which such holder is entitled and a check for cash
with respect to any fractional interest in a share of Common Stock as provided in Subsection E.3 (ii). The holder shall be deemed
to have become a stockholder of record on the applicable Conversion Date. Upon conversion of only a portion of the number of shares
of Series A Preferred represented by a certificate surrendered for conversion, the Corporation shall issue and deliver to the holder
of the certificate so surrendered for conversion, at the expense of the Corporation, a new certificate representing the number
of shares of Series A Preferred not so converted.

 

(ii) No
fractional shares of Common Stock or scrip shall be issued upon conversion of shares of Series A Preferred. If more than one share
of Series A Preferred shall be surrendered for conversion at any one time by the same holder, the number of full shares of Common
Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of Series A Preferred so
surrendered. Instead of any fractional shares of Common Stock that would otherwise be issuable upon conversion of any shares of
Series A Preferred, the Corporation shall pay a cash adjustment in respect of such fractional interest equal to the value of such
fractional interest based upon the Current Market Price of the Common Stock on the Conversion Date. For purposes of this Subsection
E.3(ii), the “Current Market Price” means, for any date, the price determined by the first of the following
clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the closing sale price per share of
the Common Stock for such date (or the nearest preceding date) on the primary Trading Market or exchange on which the Common Stock
is then listed or quoted; (b) if prices for the Common Stock are then reported in the “Pink Sheets” published by the
Pink Sheets, LLC (or a similar organization or agency succeeding to its functions of reporting prices), the most recent sale price
per share of the Common Stock so reported; or (c) in all other cases, the fair market value of a share of Common Stock as determined
by an independent qualified appraiser selected in good faith and paid for by the Investor. Notwithstanding the foregoing, if there
is no reported closing price, last reported sales price, or bid and ask prices, as the case may be, for the day in question, then
the Current Market Price shall be determined as of the latest date prior to such day for which such closing price, last reported
sales price, or bid and ask prices, as the case may be, are available, unless such securities have not been traded on an exchange
or in the over-the-counter market for 30 or more days immediately prior to the day in question, in which case the Current Market
Price shall be determined in good faith by, and reflected in a formal resolution of, the Board of Directors of the Corporation.
For purposes hereof, “Trading Market” means any of the following markets or exchanges on which the Common Stock
is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the
Nasdaq Global Select Market, the New York Stock Exchange, the OTCQB, the OTCQX or the OTC Pink (or any successors to any of the
foregoing).

 

    4

     

    

 

(iii)  The
Corporation shall pay any and all issue and other taxes that may be payable in respect of any issue or delivery of shares of Common
Stock on conversion of Series A Preferred pursuant hereto. The Corporation shall not, however, be required to pay any tax that
may be payable in respect of any transfer involved in the issue and delivery of shares of Common Stock in a name other than that
in which the Series A Preferred so converted was registered, and no such issue or delivery shall be made unless and until the person
requesting such issue has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation,
that such tax has been paid.

 

(iv) The
Corporation shall use its reasonable best efforts to reserve and keep available, out of its authorized but unissued Common Stock,
solely for the purpose of effecting the conversion of Series A Preferred, the full number of shares of Common Stock deliverable
upon the conversion of all Series A Preferred from time to time outstanding. The Corporation shall from time to time use its best
efforts to obtain necessary director and stockholder approvals, in accordance with the laws of the State of Florida, to increase
the authorized amount of its Common Stock if at any time the authorized amount of its Common Stock remaining unissued shall not
be sufficient to permit the conversion of all of the shares of Series A Preferred at the time outstanding, and shall take all such
actions as are necessary to increase such authorized amount of Common Stock upon obtaining such approvals.

 

(v) If
any shares of Common Stock to be reserved for the purpose of conversion of shares of Series A Preferred require registration or
listing with, or approval of, any governmental authority, stock exchange or other regulatory body under any federal or state law
or regulation or otherwise, before such shares may be validly issued or delivered upon conversion, the Corporation will in good
faith and as expeditiously as possible endeavor to secure such registration, listing or approval, as the case may be.

 

(vi) Assuming
there are a sufficient number of authorized shares of Common Stock available for issuance, all shares of Common Stock that may
be issued upon conversion of the shares of Series A Preferred will upon issuance by the Corporation be validly issued, fully paid
and nonassessable and free from all taxes, liens and charges with respect to the issuance thereof.

 

(vii) The
Corporation will not, by amendment of the Certificate of Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms to be observed or performed hereunder by the Corporation, but will at all times in good faith assist in the
carrying out of all of the provisions of this Section E and in the taking of all such action as may be necessary or appropriate
in order to protect the conversion rights of the holders of the Series A Preferred against impairment.

 

    5

     

    

 

(viii) Assuming
there are a sufficient number of authorized shares of Common Stock available for issuance upon such conversion, if by the third
trading day after a Conversion Date the Corporation fails to deliver the required number of shares of Common Stock underlying the
Series A Preferred in the manner required pursuant to this Subsection E.3, then the applicable holder of Series A Preferred will
have the right to rescind such conversion.

 

(ix) Assuming
there are a sufficient number of authorized shares of Common Stock available for issuance upon such conversion, if by the third
(3rd) trading day after a Conversion Date the Corporation fails to deliver the required number of shares of Common Stock
underlying the Series A Preferred in the manner required pursuant to this Subsection E.3, and if after such third (3rd)
trading day and prior to the receipt of such shares of Common Stock, shares of Common Stock are purchased by or for the account
of the applicable holder of Series A Preferred (in an open market transaction or otherwise) to deliver in satisfaction of a sale
by such holder of the underlying shares of Common Stock which such holder anticipated receiving upon such conversion (a “Buy-In”),
then the Corporation shall (1) pay in cash to such holder the amount by which (x) such holder’s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the
number of underlying shares of Common Stock that the Corporation was required to deliver to such holder in connection with such
conversion by (B) the closing price of the Common Stock on the Conversion Date and (2) at the option of such holder, either reinstate
the number of shares of Series A Preferred for which such conversion was not honored or deliver to such holder the number of shares
of Common Stock that would have been issued had the Corporation timely complied with its conversion and delivery obligations hereunder.
Any such holder of Series A Preferred shall provide the Corporation written notice indicating the amounts payable to such holder
in respect of the Buy-In.

 

    6

     

    

 

F. Mandatory
Redemption upon Bankruptcy Triggering Event. Notwithstanding anything to the contrary herein, and notwithstanding any conversion
that is then required or in process, upon any Bankruptcy Triggering Event, the Corporation shall immediately redeem, in cash, each
of the Series A Preferred then outstanding at the Preferred Liquidation Preference, without the requirement for any notice or demand
or other action by the holder of Series A Preferred or any other person or entity, provided that such holder may, in its sole discretion,
waive such right to receive payment upon a Bankruptcy Triggering Event, in whole or in part, and any such waiver shall not affect
any other rights of such holder or any other holder hereunder, including any other rights in respect of such Bankruptcy Triggering
Event, any right to conversion, and any right to payment of the Preferred Liquidation Preference. Such mandatory redemption right
shall be secured by a first priority security interest on all of the Corporation’s assets. For purposes hereof, “Bankruptcy
Triggering Event” means, (i) bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for
the relief of debtors shall be instituted by or against the Corporation and, if instituted against the Corporation by a third party,
shall not be dismissed within ninety (90) days of their initiation, (ii) the commencement by the Corporation of a voluntary case
or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or of
any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent by it to the entry of a decree, order, judgment
or other similar document in respect of the Corporation in an involuntary case or proceeding under any applicable federal, state
or foreign bankruptcy, insolvency, reorganization or other similar law or to the commencement of any bankruptcy or insolvency case
or proceeding against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under any applicable
federal, state or foreign law, or the consent by it to the filing of such petition or to the appointment of or taking possession
by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Corporation or of any substantial
part of its property, or the making by it of an assignment for the benefit of creditor, or the execution of a composition of debts,
or the occurrence of any other similar federal, state or foreign proceeding, or the admission by it in writing or its inability
to pay its debts generally as they become due, the taking of corporate action by the Corporation in furtherance of any such action
or the taking of any action by any person or entity to commence a Uniform Commercial Code foreclosure sale or any other similar
action under federal, state or foreign law or (iii) the entry by a court of (a) a decree, order, judgment or other similar document
in respect of the Corporation of a voluntary or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy,
insolvency, reorganization or other similar law or (b) a decree, order, judgment or other similar document adjudging the Corporation
as bankrupt or insolvent, or approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment
or composition of or in respect of the Company or any Subsidiary under any applicable federal, state or foreign law or (c) a decree,
order, judgment or other similar document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other
similar official of the Company or of any substantial part of its property, or ordering the winding up or liquidation of its affairs,
and the continuance of any such decree, order, judgment or other similar document or any such other decree, order, judgment or
other similar document unstayed and in effect for a period of ninety (90) consecutive days.

 

G. Participation
Rights. So long as at least 50% of the Series A Preferred issued remains outstanding, if at any time the Corporation grants,
issues or sells any Common Stock or any other securities of the Corporation that would entitle the holder thereof to acquire at
any time Common Stock, including, without limitation, any preferred stock, right, option, warrant or other instrument that is at
any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock
(“Common Stock Equivalents”) or rights to purchase stock, warrants or equity securities to any person or entity
(the “Purchase Rights”), then the holders of Series A Preferred will be entitled to acquire, upon the terms
applicable to such Purchase Rights, ratably, the aggregate Purchase Rights which such holder could have acquired if the holder
had held the number of shares of Common Stock acquirable upon complete conversion of such holder’s Series A Preferred immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights.

 

    7

     

    

 

H. Subsequent
Equity Sales. If at any time, while the Series A Preferred is outstanding, the Corporation enters into (without the prior written
consent of the holders of Series A Preferred), a transaction involving the sale or grant of any option to purchase or sells or
grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other
disposition), any Common Stock or Common Stock Equivalents entitling any person or entity to acquire shares of Common Stock at
a determinable effective price per share that is lower than the Conversion Price (such lower price, the “Base Conversion
Price” and such issuances, collectively, a “Dilutive Issuance”) (if the holder of the Common Stock
or Common Stock Equivalents so issued as part of such transaction shall at any time, whether by operation of purchase price adjustments,
reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share
which are issued in connection with such issuance, be entitled to receive shares of Common Stock at a determinable effective price
per share that is lower than the Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion
Price on such date of Dilutive Issuance), then the Conversion Price shall be reduced to equal the Base Conversion Price. Such adjustment
shall be made whenever such Common Stock or Common Stock Equivalents are issued and the Base Conversion Price is determinable.
Notwithstanding the foregoing, no adjustment will be made under this Section H in respect of an “Exempt Issuance.”
For the purposes hereof, an Exempt Issuance shall consist of any issuance pursuant to (i) existing warrants and options, (ii) employee
options approved by the Corporation’s Board of Directors and (iii) strategic business transactions. The Corporation shall
notify the holders of Series A Preferred in writing, no later than the trading day following the issuance of any Common Stock or
Common Stock Equivalents subject to this Section H, indicating therein the applicable issuance price, or applicable reset price,
exchange price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”).

 

I.  Amendment;
Waiver. Any term of the Series A Preferred may be amended or waived upon the written consent of the Corporation and the holders
of a majority-in-interest of all the Series A Preferred then outstanding, voting together as a single class; provided, however,
that the right to convert the Series A Preferred may not be altered or waived, without the written consent of the holders of all
of the Series A Preferred then outstanding; and provided, further, that no such amendment or waiver may adversely affect the rights
of any holder without such holder’s written consent.

 

J. Action
By Holders. Any action or consent to be taken or given by the holders of the Series A Preferred may be given either at a meeting
of the holders of the Series A Preferred called and held for such purpose or by written consent.

 

IN WITNESS WHEREOF,
NanoFlex Power Corporation has caused this Certificate to be signed by Dean L. Ledger, its Chief Executive Officer, this 15 day
of February 2019.

 

	 	NANOFLEX POWER CORPORATION
	 	 	 	 
	 	By:	/s/ Dean L. Ledger
	 	 	Name: 	Dean L. Ledger
	 	 	Title:	CEO

 

 

8Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

 This SECURITIES PURCHASE AGREEMENT
(the “Agreement”), dated as of February 21, 2019, by and between NANOFLEX POWER CORPORATION, a Florida corporation,
with its address at 17207 N. Perimeter Dr., Suite 210, Scottsdale, AZ 85255 (the “Company”), and POWER UP LENDING
GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the “Buyer”).

 

WHEREAS:

 

A. The
Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under
the Securities Act of 1933, as amended (the “1933 Act”); and

 

B. Buyer
desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a convertible
note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $63,000.00 (together with any
note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof,
the “Note”), convertible into shares of common stock, $0.0001 par value per share, of the Company (the “Common
Stock”), upon the terms and subject to the limitations and conditions set forth in such Note.

 

NOW THEREFORE, the Company and the
Buyer severally (and not jointly) hereby agree as follows:

 

1. Purchase and
Sale of Note. 

 

a. 
 Purchase of Note. On the Closing
Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase from the Company such principal
amount of Note as is set forth immediately below the Buyer’s name on the signature pages hereto.

 

b. Form
of Payment. On the Closing Date (as defined below), (i) the Buyer shall pay the purchase price for the Note to be issued and
sold to it at the Closing (as defined below) (the “Purchase Price”) by wire transfer of immediately available funds
to the Company, in accordance with the Company’s written wiring instructions, against delivery of the Note in the principal
amount equal to the Purchase Price as is set forth immediately below the Buyer’s name on the signature pages hereto, and
(ii) the Company shall deliver such duly executed Note on behalf of the Company, to the Buyer, against delivery of such Purchase
Price.

 

c. Closing
Date. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below,
the date and time of the issuance and sale of the Note pursuant to this Agreement (the “Closing Date”) shall be 12:00
noon, Eastern Standard Time on or about February 25, 2019, or such other mutually agreed upon time. The closing of the transactions
  contemplated by this Agreement (the
“Closing”) shall occur on the Closing Date at such location as may be agreed to by the parties.

 

     

     

    

 

2. Buyer’s
Representations and Warranties. The Buyer represents and warrants to the Company that:

 

a. Investment
Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon conversion of
or otherwise pursuant to the Note (such shares of Common Stock being collectively referred to herein as the “Conversion Shares”
and, collectively with the Note, the “Securities”) for its own account and not with a present view towards the public
sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.

 

b. Accredited
investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D (an
“Accredited Investor”).

 

c. Reliance
on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the
Buyer to acquire the Securities.

 

d. Information.
The Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information unless such
information is disclosed to the public prior to or promptly following such disclosure to the Buyer.

 

e. Legends.
The Buyer understands that the Note and, until such time as the Conversion Shares have been registered under the 1933 Act; or may
be sold pursuant to an applicable exemption from registration, the Conversion Shares may bear a restrictive legend in substantially
the following form:

 

“THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED
UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANYAPPLICABLE STATE SECURITIES
LAWS OR (2) THE ISSUER OF SUCH SECURITIES RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION
ARE REASONABLY ACCEPTABLE TO THE ISSUER’S TRANSFER AGENT, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED
OR OTHERWISE    TRANSFERRED
WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.”

 

    2

     

    

 

The legend set forth
above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security upon which it
is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under an
effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to an exemption from registration without
any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such holder provides
the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions,
to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion
shall be accepted by the Company so that the sale or transfer is effected. The Buyer agrees to sell all Securities, including those
represented by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements,
if any. In the event that the Company does not accept the opinion of counsel provided by the Buyer with respect to the transfer
of Securities pursuant to an exemption from registration, such as Rule 144, at the Deadline, it will be considered an Event of
Default pursuant to Section 3.2 of the Note so long as such opinion is in compliance with the 1933 Act.

 

f. Authorization;
Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf
of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms.

 

3. Representations
and Warranties of the Company. The Company represents and warrants to the Buyer that:

 

a. Organization
and Qualification. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized, validly
existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. “Subsidiaries” means any corporation or other organization, whether incorporated or unincorporated,
in which the Company owns, directly or indirectly, any equity or other ownership interest.

 

b.
Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this
Agreement, the Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance
with the terms hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation
by it of the transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance
and reservation for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized
by the Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its
shareholders is required, (iii) this Agreement has been duly executed and delivered by the Company by its authorized representative,
and such authorized representative is the true and official representative with authority to sign this Agreement and the other
documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon
execution and delivery by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation
of the Company enforceable against the Company in accordance with its terms.

 

    3

     

    

 

c.
Capitalization. As of the date hereof, the authorized common stock of the Company consists of 500,000,000 authorized shares
of Common Stock, $0.0001 par value per share, of which 131,170,839 shares are issued and outstanding; and 17,035,659 shares are
planned to be reserved for issuance upon conversion of the Note. All of such outstanding shares of capital stock are, or upon
issuance will be, duly authorized, validly issued, fully paid and non-assessable.

 

d. Issuance
of Shares. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note in accordance
with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances
with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the
Company and will not impose personal liability upon the holder thereof.

 

e. No
Conflicts. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance
of the Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation
or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which
with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries
is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state
securities laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities are
subject) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries
is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations
as would not, individually or in the aggregate, have a Material Adverse Effect). The businesses of the Company and its Subsidiaries,
if any, are not being conducted, and shall not be conducted so long as the Buyer owns any of the Securities, in violation of any
law, ordinance or regulation of any governmental entity. “Material Adverse Effect” means any material adverse effect
on the business, operations, assets, financial condition or prospects of the Company or its Subsidiaries, if any, taken as a whole,
or on the transactions contemplated hereby or by the agreements or instruments to be entered into in connection herewith,
provided, however, that none of the following, either alone or in combination, will constitute, or be considered in determining
whether there has been, a Material Adverse Effect: any event, change, circumstance, effect or other matter resulting from or related
to (i) any outbreak or escalation of war or major hostilities or any act of terrorism, (ii) changes in Laws, GAAP or enforcement
(provided that such enforcement does not result in an Event of Default) or interpretation thereof, (iii) changes that generally
affect the industries and markets
in which the Company operates or (iv) changes in financial
markets, general economic conditions (including prevailing interest rates, exchange rates, commodity prices) or political conditions.

 

    4

     

    

  

f. SEC
Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as
amended (the “1934 Act”) (all of the foregoing filed prior to the date hereof and all exhibits included therein
and financial statements and schedules thereto and documents (other than exhibits to such documents) incorporated by
reference therein, being hereinafter referred to herein as the “SEC Documents”). Upon written request the Company
will deliver to the Buyer true and complete copies of the SEC Documents, except for such exhibits and incorporated documents.
As of their respective dates or if amended, as of the dates of the amendments, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to
the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading. None of the statements made in
any such SEC Documents is, or has been, required to be amended or updated under applicable law (except for such statements as
have been amended or updated in subsequent filings prior the date hereof). As of their respective dates or if amended, as of
the dates of the amendments, the financial statements of the Company included in the SEC Documents complied as to form in all
material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect
thereto. Such financial statements have been prepared in accordance with United States generally accepted
accounting principles, consistently applied, during the periods involved and fairly present in all material respects the
consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to
normal year-end audit adjustments). The Company is subject to the reporting requirements of the 1934 Act.

 

g. Absence
of Certain Changes. Since September 30, 2018, except as set forth in the SEC Documents, there has been no material adverse
change and no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results
of operations, prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.

 

h. Absence
of Litigation. Except as set forth in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation
before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the
Company or any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or
directors in their capacity as such, that could have a Material Adverse Effect. The Company and its Subsidiaries are unaware of
any facts or circumstances which might give rise to any of the foregoing.

 

    5

     

    

 

i. No
Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any
  security or solicited any offers to
buy any security under circumstances that would require registration under the 1933 Act of the issuance of the Securities to the
Buyer. The issuance of the Securities to the Buyer will not be integrated with any other issuance of the Company’s securities
(past, current or future) for purposes of any shareholder approval provisions applicable to the Company or its securities.

 

j. No
Brokers. Except for Garden State Securities, Inc., the Company has taken no action which would give rise to any claim by any
person for brokerage commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated
hereby.

 

k. No
Investment Company. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement
will not be an “investment company” required to be registered under the Investment Company Act of 1940 (an “Investment
Company”). The Company is not controlled by an Investment Company.

 

I. Breach
of Representations and Warranties by the Company. If the Company breaches any of the representations or warranties set forth
in this Section 3, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered
an Event of default under Section 3.4 of the Note.

 

4. COVENANTS.

 

a. 
 Best Efforts. The Company shall
use its best efforts to satisfy timely each of the conditions described in Section 7 of this Agreement.

 

b. Form
D; Blue Sky Laws. The Company agrees to timely make any filings required by federal and state laws as a result of the closing
of the transactions contemplated by this Agreement.

 

c. Use
of Proceeds. The Company shall use the proceeds for general working capital purposes.

 

d. Expenses.
At the Closing, the Company’s obligation with respect to the transactions contemplated by this Agreement is to reimburse
Buyer’ expenses shall be $3,000.00 for Buyer’s legal fees and due diligence fee.

 

e. Corporate
Existence. So long as the Buyer beneficially owns any Note, the Company shall maintain its corporate existence and shall not
sell all or substantially all of the Company’s assets, except with the prior written consent of the Buyer.

 

    6

     

    

 

f. 
 Breach of Covenants. If the
Company breaches any of the covenants set forth in this Section 4, and in addition to any other remedies available to the Buyer
pursuant to this Agreement, it will be considered an event of default under Section 3.4 of the Note.

 

g. Failure
to Comply with the 1934 Act. So long as the Buyer beneficially owns the Note, the Company shall comply with the reporting requirements
of the 1934 Act; and the Company shall continue to be subject to the reporting requirements of the 1934 Act.

 

5. Transfer
Agent Instructions. The Company shall use its best efforts to issue irrevocable instructions to its transfer agent to issue
certificates, registered in the name of the Buyer or its nominee, for the Conversion Shares in such amounts as specified from time
to time by the Buyer to the Company upon conversion of the Note in accordance with the terms thereof (the “Irrevocable Transfer
Agent Instructions”). In the event that the Company proposes to replace its transfer agent, the Company shall provide, prior
to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to this Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved
Amount as such term is defined in the Note) signed by the successor transfer agent to Company and the Company. Prior to registration
of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares may be sold pursuant to an exemption from
registration, all such certificates shall bear the restrictive legend specified in Section 2(e) of this Agreement. The Company
warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5, will be
given by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books and records
of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its transfer agent not to
transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)(electronically or in certificated form)
any certificate for Conversion Shares to be issued to the Buyer upon conversion of or otherwise pursuant to the Note as and when
required by the Note and this Agreement; and (iii) it will not fail to remove (or directs its transfer agent not to remove or impairs,
delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions
in respect thereof) on any certificate for any Conversion Shares issued to the Buyer upon conversion of or otherwise pursuant to
the Note as and when required by the Note and/or this Agreement so long as such removal is in compliance with the 1933 Act. If
the Buyer provides the Company and the Company’s transfer, at the cost of the Buyer, with an opinion of counsel in form,
substance and scope customary for opinions in comparable transactions, to the effect that a public sale or transfer of such Securities
may be made without registration under the 1933 Act, the Company shall permit the transfer, and, in the case of the Conversion
Shares, promptly instruct its transfer agent to issue one or more certificates, free from restrictive legend, in such name and
in such denominations as specified by the Buyer. The Company acknowledges that a breach by it of its obligations hereunder will
cause irreparable harm to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly,
the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5 may be inadequate and agrees,
in the event of a breach or threatened breach by the Company of the provisions of this Section, that the Buyer shall be entitled,
in addition to all other available remedies, to an injunction restraining any breach and requiring immediate transfer.

 

    7

     

    

 

  6. Conditions to the Company’s
Obligation to Sell. The obligation of the Company hereunder to issue and sell the Note to the Buyer at the Closing is subject
to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided that these conditions
are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

 

a. The
Buyer shall have executed this Agreement and delivered the same to the Company.

 

b. The
Buyer shall have delivered the Purchase Price in accordance with Section 1(b) above.

 

c. The
representations and warranties of the Buyer shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date), and
the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing Date.

 

d. No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

 7. Conditions to The Buyer’s Obligation to Purchase.
The obligation of the Buyer hereunder to purchase the Note at the Closing is subject to the satisfaction, at or before the Closing
Date of each of the following conditions, provided that these conditions are for the Buyer’s sole benefit and may be waived
by the Buyer at any time in its sole discretion:

 

a. The
Company shall have executed this Agreement and delivered the same to the Buyer.

 

b. The
Company shall have delivered to the Buyer the duly executed Note (in such denominations as the Buyer shall request) in accordance
with Section 1(b) above.

 

c. The
Irrevocable Transfer Agent Instructions, in form and substance satisfactory to the Buyer, shall have been delivered to and acknowledged
in writing by the Company’s Transfer Agent.

 

    8

     

    

 

d. The
representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though made at such time (except for representations and warranties that speak as of a specific date) and
the Company    shall
have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date, The Buyer shall have received
a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing Date, to the foregoing
effect and as to such other matters as may be reasonably requested by the Buyer including, but not limited to certificates with
respect to the Board of Directors’ resolutions relating to the transactions contemplated hereby.

 

e. No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

f. No
event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not
limited to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act
reporting obligations.

 

g. The
Conversion Shares shall have been authorized for quotation on an exchange or electronic quotation system and trading in the Common
Stock on such exchange or electronic quotation system shall not have been suspended by the SEC or an exchange or electronic quotation
system.

 

h. The
Buyer shall have received an officer’s certificate described in Section 3(d) above, dated as of the Closing Date.

 

8. Governing Law;
Miscellaneous.

 

 a. Governing Law. This Agreement
shall be governed by and construed in accordance with the laws of the State of Virginia without regard to principles of conflicts
of laws. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall
be brought only in the state courts of New York or in the federal courts located in the state and county of Nassau. The parties
to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall
not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The Company and Buyer
waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees
and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid
or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement, the Note or any related document or
  agreement by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

    9

     

    

 

b. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party.

 

c. Headings.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of,
this Agreement.

 

d. Severability.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

e. Entire
Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company
nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement
may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

 

f. Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed
effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine,
at the address or number designated below (if delivered on a business day during normal business hours where such notice is to
be received), or the first business day following such delivery (if delivered other than on a business day during normal business
hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service,
fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for
such communications shall be as set forth in the heading of this Agreement with a copy by fax only to (which copy shall not constitute
notice) to Naidich Wurman LLP, 111 Great Neck Road, Suite 214, Great Neck, NY 11021, Attn: Allison Naidich, facsimile: 516-466-3555,
e-mail: allison@nwlaw.com. Each party shall provide notice to the other party of any change in address.

 

    10

     

    

 

g. Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.
Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any person that purchases Securities
in a private transaction from the Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act,
without the consent of the Company.

 

h. Survival.
The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the
closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees to
indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage arising as a result
of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth
in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.

 

i. Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

j. No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

k. Remedies.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating
the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for
a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by
the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies
at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing
or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof.

 

[THE REMAINDER OF
THIS PAGE IS INTENTIONALLY LEFT BLANK]

 

    11

     

    

 

IN WITNESS WHEREOF, the undersigned Buyer
and the Company have caused this Agreement to be duly executed as of the date first above written.

 

	NANOFLEX POWER CORPORATION	 
	 	 	 
	By:	/s/ Dean L. Ledger	 
	 	Dean L. Ledger	 
	 	Chief Executive Officer	 
	 	 	 
	POWER UP LENDING GROUP LTD.	 
	 	 	 
	By:	/s/ Curt Kramer	 
	Name: 	Curt Kramer	 
	Title:	Chief Executive Officer 	 
	111 Great Neck Road, Suite 216 	 
	Great Neck, NY 11021	 

 

AGGREGATE SUBSCRIPTION AMOUNT:

 

	Aggregate Principal Amount of Note:	 	$	63,000.00	 
	 	 	 	 	 
	Aggregate Purchase Price:	 	$	63,000.00	 

 

 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]